A case of intestinal tumor formation during gilteritinib therapy that resolved without discontinuing the drug.

Saved in:
Bibliographic Details
Title: A case of intestinal tumor formation during gilteritinib therapy that resolved without discontinuing the drug.
Authors: Oka K; Department of Hematology, Uwajima City Hospital, 1-1 Goten-machi, Uwajima, Ehime, 798- 8510, Japan. oka.koji.ak@ehime-u.ac.jp., Shikata H; Department of Hematology, Uwajima City Hospital, 1-1 Goten-machi, Uwajima, Ehime, 798- 8510, Japan., Kaneko M; Department of Hematology, Uwajima City Hospital, 1-1 Goten-machi, Uwajima, Ehime, 798- 8510, Japan., Matsukage S; Department of Pathology, Uwajima City Hospital, Uwajima, Ehime, 798- 8510, Japan.
Source: Clinical journal of gastroenterology [Clin J Gastroenterol] 2026 Apr; Vol. 19 (2), pp. 400-405. Date of Electronic Publication: 2026 Feb 23.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 101477246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-7265 (Electronic) Linking ISSN: 18657265 NLM ISO Abbreviation: Clin J Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1865-7265
DOI:10.1007/s12328-026-02282-8